Invasive aspergillosis and other fungal infections occur in immunocompromised individuals, including patients who received blood-building stem cell transplants, patients with chronic granulomatous disease (CGD), and others. Production of reactive oxygen species (ROS) by immune cells, which incidentally is defective in CGD patients, is considered to be a fundamental process in inflammation and antifungal immune response. Here we show that the peroxiredoxin Asp f3 of Aspergillus fumigatus inactivates ROS. We report the crystal structure and the catalytic mechanism of Asp f3, a two-cysteine type peroxiredoxin. The latter exhibits a thioredoxin fold and a homodimeric structure with two intermolecular disulfide bonds in its oxidized state. Replacement of the Asp f3 cysteines with serine residues retained its dimeric structure, but diminished Asp f3’s peroxidase activity, and extended the alpha-helix with the former peroxidatic cysteine residue C61 by six residues. The asp f3 deletion mutant was sensitive to ROS, and this phenotype was rescued by ectopic expression of Asp f3. Furthermore, we showed that deletion of asp f3 rendered A. fumigatus avirulent in a mouse model of pulmonary aspergillosis. The conserved expression of Asp f3 homologs in medically relevant molds and yeasts prompts future evaluation of Asp f3 as a potential therapeutic target.
The opportunistic pathogen Aspergillus fumigatus is a filamentous fungus that is ubiquitously distributed throughout the environment. As a saprophyte it contributes to biomass recycling by decomposing decaying plant materials1,2. In hypersensitive individuals inhaled A. fumigatus spores (conidia) are responsible for allergic bronchopulmonary aspergillosis (ABPA), also known as farmer’s lungs. More importantly, A. fumigatus can cause severe debilitating and oftentimes lethal infections in immunocompromized patients. Invasive fungal infections such as invasive aspergillosis are predominantly caused by A. fumigatus and represent the prime obstacle to the success of hematopoietic stem cell transplantation in the cancer clinic1,3,4.
Reduced production of host derived reactive oxygen species (ROS), as in patients with chronic granulomatous disease (CGD), is regarded as one of the highest risk factors5, although the defensive role of ROS in fungal immunity is not fully understood. Reactive oxygen species generated by innate immune cells are components of the fundamental defense mechanism against infection with A. fumigatus, but whether these toxic molecules target the fungus directly is not known. Here, we have studied the A. fumigatus protein Asp f3 and its role for the protection of the fungus against ROS.
The intracellular Asp f3 is an abundant protein in A. fumigatus. Asp f3 was originally identified as a major fungal allergen with affinity to serum immunoglobulin (Ig)E from patients with ABPA6. However, it was also shown that Asp f3 can serve as a promising vaccine candidate7,8. Asp f3-immunized mice were protected from experimentally induced invasive pulmonary aspergillosis in both corticosteroid immunosuppressed and in neutrophil depleted mice9. In the fungus, Asp f3 co-localizes with peroxisomes and shows peroxide dependent up-regulation at the transcriptional and translational level8,10. It contains 168 amino acid residues and BLAST searches reveal considerable sequence homology to the thioredoxin superfamily, the peroxiredoxin (Prx) family, and the PRX5-like subfamily.
Here, we report the crystal structure of Asp f3 as a dimeric molecule with two interchain disulfide bonds. We experimentally confirm the predicted peroxiredoxin activity of Asp f3 and demonstrate the functional contribution of its cysteine residues for catalytic activity. We show that Asp f3 is indispensible for the protection of A. fumigatus against oxidative stressors. Finally, we provide evidence for the critical role of Asp f3 in fungal virulence, wherein it protects A. fumigatus against oxidative stress in vitro, and in vivo, in a murine model of invasive pulmonary aspergillosis.
Asp f3 Structure Determination
Aspf3 wild type (WT) and its C31S/C61S variant crystallized as a homodimer and showed a typical thioredoxin-like fold11,12,13. The WT protein was captured in its oxidized state, with two intermolecular disulfide bonds across the dimerization interface between C31 and C61 of the individual protomers (Fig. 1, and Supplementary Fig. S1). Searches using DALI14 indicate that the structure is very similar to recently published structure of yeast peroxiredoxin Ahp1, PDB ID 4DSQ (RMSD of 1.4 Å)15. In the WT structure, both C31 and C61 reside in flexible loop regions (large B-factors and lack of well-defined electron density for one of the chains). The serine variant showed little overall structural change (RMSD 1.7 Å), with large deviation of the aforementioned loops (residues 24–35 and 58–64 RMSD > 4.0 Å). Disruption of the intermolecular disulfide bond in C31S/C61S variant extends the α-helix by 6 residues resulting in a significant movement of S61 by ~7–9 Å from the position occupied by C61 in the WT structure (Fig. 2, Table 1), analogous to the movement of C62 in the reduced form of Ahp115. A corresponding movement of S31 by 4–5 Å is likely driven by formation of a hydrogen bond to backbone oxygen of F57. Further details regarding the inter-chain interactions of both structures are given in Supplementary Table S1.
Sedimentation equilibrium studies by analytical ultracentrifugation of WT Aspf3 and C31S/C61S proteins indicate that the dimerization is independent of the Cys oxidation state (Supplementary Fig. S2). Global fit analysis of sedimentation equilibrium experiments of WT Aspf3 and C31S/C61S revealed the presence of a dimer (SEDPHAT calculated molecular weight – 36 kDa and 37.3 kDa for WT and C31S/C61S, respectively; theoretical molecular weight – 38.6 kDa). Sedimentation equilibrium experiment performed on WT protein in the presence of excess TCEP revealed the presence of the dimer (calculated MW of 35.5 kDa). The Asp f3 C31S/C61S dimer, as well as the reduced WT Asp f3 separate primarily as monomers under the chaotropic conditions of SDS gel electrophoresis (Supplementary Fig. S3E).
Biochemical evaluation of the Asp f3 peroxidase (Prx) activity
To confirm that Asp f3 indeed exhibits the predicted Prx activity, we conducted two independent biochemical assays on WT Asp f3, its cysteine/serine (Cys/Ser) mutants, and the corresponding cysteine/alanine (Cys/Ala) mutants. Direct assessment of Prx was conducted by measuring Prx-dependent conversion of 10-acetyl-3,7-dihydroxyphenoxazine (Ampliflu Red) to fluorescent 7-hydroxyphenoxazin-3-one (Resorufin) in presence of thioredoxin, hydrogen peroxide or tert-butyl hydroperoxide (t-bOOH) (Fig. 3a–c); Secondly, Prx activity was determined indirectly, by colorimetric evaluation of the NAPDH oxidation as a consequence of glutathione reductase activity which recycles Prx activity in presence of t-bOOH (Fig. 3d,e). Both Cys/Ser as well as Cys/Ala replacements in Asp f3 dramatically lowered its peroxiredoxin activity with t-bOOH and H2O2 (Fig. 3a,c). These observations indicated that C31 and C61 are involved in the catalytic mechanism of Asp f3.
Kinetic constants were determined for the WT and its cysteine double mutants (Table 2, Fig. 3c). Cysteine replacement decreased the enzymatic turnover rate (kcat) of the WT by 2.6 to 6.8-fold with t-bOOH, and 4 to 12-fold with H2O2 for C31A/C61A and C31S/C61S mutants, respectively (Fluorometric Assay, Table 2 and Fig. 3c). A three-fold reduction of the WT catalytic efficiency rate (kcat/Km) was determined for C31A/C61A, and a ten-fold reduction for C31S/C61S with t-bOOH or H2O2, respectively (Table 2). Asp f3-dependent oxidation of NADPH in presence of glutathione reductase (Fig. 3d,e) confirmed the aforementioned results obtained with Ampliflu Red, and the kinetic data were comparable (Table 2). In comparison to the WT, a significantly lower time-dependent decrease in absorbance at 340 nm due to the oxidation of NADPH was monitored with C31A/C61A at 49% and C31S/C61S at 19% in presence of t-bOOH (Fig. 3d).
Asp f3 protects from oxidative stress
Structural and functional evidence of Asp f3 as a Prx strongly suggested that Asp f3 could provide protection against oxidative stress in vivo. Southern and Western blot analysis confirmed the successful deletion of the asp f3 gene and knock out (KO) of Asp f3 expression in A. fumigatus D141, as well as subsequent complementation of the mutant (asp f3C; Supplementary Fig. S3). The mutant was viable and growth was indistinguishable from the WT under standard growth conditions in Aspergillus Minimal Medium (AMM) at 37 °C. However, deletion of asp f3 rendered A. fumigatus sensitive to H2O2 compared WT, revealed by agar diffusion assays revealed at concentrations exceeding 30 mM H2O2 (Fig. 4A,B). Expression of the asp f3 genetic locus from an ectopic site of the genome (asp f3C) reverted peroxide sensitivities almost to WT levels. Peroxide sensitivity of the mutant was even more pronounced when using the organic hydroperoxide t-bOOH with a detectable inhibition zones at concentrations as low as 15 mM (Fig. 4C). In contrast, menadione which generates ROS through intracellular redox cycling16, was effective against A. fumigatus at less than 0.3 mM, but independent of the presence or absence of Asp f3 (Fig. 4D). To further define the in vivo-impact of the Asp f3 protein, we determined the minimal inhibitory concentrations for H2O2. During direct exposure in liquid cultures, A. fumigatus WT cells maintained growth at H2O2 levels of 1000 μM, while growth of ∆asp f3 was fully inhibited at 250 μM (Fig. 4E,F).
The asp f3 deletion mutant is hypersensitive to exposure to ·O2−
Although A. fumigatus is likely to encounter the more stable H2O2 in vivo, ·O2− represents the direct reaction product of NADPH oxidase complex (NOX) during interactions with host cells17. Hence, we tested whether extracellular ·O2− would affect fungal growth and viability. The xanthin-oxidase (XO) reaction with xanthine (X) has previously been used as an alternative enzymatic system to generate this short-lived ·O2− radical in vitro to assay bacteria or enzymes for their capability to scavenge and inactivate ·O2− 18,19,20. XO oxidizes X to uric acid with a concomitant release of ·O2− and H2O2 (Fig. 5A). Under the reaction conditions used, xanthin oxidation released ·O2− at 2:1 molar ratio based on the reduction of ferricytochrome c which was fully inhibited in the presence of an externally added superoxide dismutase20 (Supplementary Fig. S4). Conidia of the WT and the asp f3C strain grew normally over the whole concentration range of added X, from 25 to 250 μM, corresponding to ·O2− levels of 12.5 to 125 μM, respectively. In contrast thereto, the growth of the ∆asp f3 strain was drastically diminished by the X + XO treatment (Fig. 5B,C). This growth defect of the mutant was fully reverted either by the reintroduction of a functional copy of the asp f3 gene (asp f3C) or the addition of external superoxide dismutase (SOD, Fig. 5D). The toxic effect of external ·O2− was fungistatic rather than fungicidal as swollen conidia remained viable even after an exposure of 2 h, as revealed by CFU counts (Fig. 5E). ·O2− levels as low as 12.5 μM were sufficient to reduce hyphae formation below 60% of that of the untreated controls. ·O2− concentrations >25 μM were completely inhibitory for the growth of the ∆asp f3 strain, even when pre-grown to its hyphal form (Fig. 5F), giving direct evidence that the in vivo function of Asp f3 is essential to protect against low levels of extracellular ·O2−.
Asp f3 is required for A. fumigatus virulence in experimental pulmonary aspergillosis
The Prx activity of Asp f3 detected in our in vitro studies as well as its essential role in oxidative stress resistance in vivo, prompted us to test if Asp f3 could play a role during pulmonary invasive aspergillosis. Therefore, four groups of mice were immunosuppressed with cortisone acetate and animals remained uninfected (PBS-control) or were either infected with conidia of the WT, ∆asp f3, or asp f3C strain of A. fumigatus (Fig. 6). Animals infected with WT conidia died over a course of 8 days and histological analysis revealed severe signs of pulmonary aspergillosis (IA), including tissue invasion of fungal hyphae (Supplementary Fig. S5) and massive infiltration of inflammatory cells, including polymorphonuclear leukocytes (Supplementary Fig. S5). In contrast, all animals infected with conidia of the ∆asp f3 strain survived for the entire 14 day observation period without showing any clinical signs of the disease. When infected with conidia from the complemented strain asp f3C, IA developed at frequencies comparable to that of the WT and was lethal for 70% of the animals. Histological examinations of the mice surviving infection with the ∆asp f3 strain revealed only residual fungal growth without invasion of the peribronchial tissue and only a small number of inflammatory cells (Supplementary Fig. S5). The same mice showed occasional signs of goblet cell hyperplasia (Supplementary Fig. S5). In summary, infections with the asp f3 deletion strain did not lead to IA, indicating the requirement of the Asp f3 Prx for A. fumigatus virulence in the immunosuppressed animal model.
Based on sequence homology and structural information, Asp f3 was identified as a member of the 2-Cys Prx5 subfamily of the thiol-dependent peroxidase family of proteins that is similar to human Prx5 (PDB ID: 1HD2). The latter is a homodimeric Trx peroxidase that exclusively exists as an A-type dimer (in contrast to all other Prxs)21. Prx5 is widely expressed in tissues and found in mitochondria, peroxisomes and in the cytosol that are major sources of reactive oxygen species (ROS). This protein is able to reduce hydrogen peroxide and alkyl hydroperoxides with the use of reducing equivalents derived from thiol-containing donor molecules such as thioredoxin and glutathione, and known to be functionally implicated in antioxidant protective mechanisms21. This suggests that Asp f3 may have an important role in peroxide detoxification mechanism.
The crystal structure of Asp f3 revealed its homodimeric configuration that includes two intermolecular disulfide bonds (Fig. 1). The dimer interface comprises an area of ~710 Å2 and ~730 Å2 for WT and C31S/C61S variant, respectively. The slight increase in the overall dimer interface area for C31S/C61S (~730 Å2) is due to the fact that the loop connecting residues 24–31 is ordered in both protomers, whereas the backbone cannot be traced in one of the protomers in the WT structure. Salt bridges between R131 and D91 from the two protomers and additional hydrogen bonds between main chain atoms (T29-V60, A30-V60, A30-C61), as well as residues involved in hydrophobic interactions (I28, A30, F57, P59, V60, V94, Y93, A97) contribute to the extensive interface interactions. The WT, as well as C31S/C61S variant, exhibited close similarity to oxidized and reduced forms of Ahp1, respectively15. S61 in C31S/C61S of Asp f3 becomes more buried, much like C62 in the reduced form of Ahp1. Therefore, we expect that the structure of the C31S/C61S mutant to bear close resemblance with that of the reduced dimeric Asp f3 WT.
Each monomer contains the PGAFTPVC redox center motif that defines a catalytic triad of Pro, Thr, and Cys. The PxxxTxxC active site motif is highly conserved in Prx5 proteins22 (Supplementary Fig. S6), wherein the cysteine sulfur is coordinated by Thr (Ser) and Arg. The residue at the active site (C61) is the peroxidatic cysteine (CP) that initiates the peroxide reduction by nucleophilic attack, when present in its thiolate form. Deprotonation of the CP is facilitated by H-bonding with the threonine hydroxyl group and the positive charge of the arginine guanidinium group (Fig. 2). This is followed by generation of the sulfenic acid form of CP and the alcohol product (ROH) of the reduced peroxide substrate (Fig. 3b). Indeed, our C61A or C61S mutations drastically reduce the Asp f3 Prx activity in presence of t-bOOH or H2O2 (Fig. 3a). The second Cys residue (C31) is therefore designated as the resolving cysteine (CR) that participates in catalysis in later reaction step. Disulfide reductases such as a thioredoxin or glutaredoxin return oxidized Asp f3 to its activated, reduced state.
Our data are consistent with a previous report on an Asp f3 homologue, the 2-Cys yeast peroxiredoxin Ahp115. Although Ahp1 and Asp f3 share only about 37% sequence identity, the positions of CP and CR are conserved and both located in the same sequence orientation with CR closest to the N-terminus (Fig. S5). The dimeric interface of Asp f3 is similar to that of Ahp1, but it differs at several key positions. First, N90 and D91 in Asp f3 are reversed in Ahp1 (Supplementary Fig. S6). In Asp f3, the side chain of D91 caps α-helix 2 (Supplementary Fig. S7). To compensate for the charge, R131 from the other Asp f3 protomer makes a salt bridge to the side chain carboxylate (distance = 3.0 Å). The equivalent residue in Ahp1 is a tryptophan. In addition, Y89 in Asp f3 in the same protomer makes a hydrogen bond to R131 (3.3 Å, Supplementary Fig. S7). The equivalent residue in Ahp1 is a valine. Noteworthy, this part of the interface is not affected by the large conformational change that involves the redox active cysteines. Additional compensatory changes occur throughout the structure, preserving the fold and dimeric interface while reducing the overall sequence identity.
Asp f3’s enzymatic activity on peroxides and structural similarity to the previously characterized yeast-orthologue Ahp1, suggested that Asp f3 could counteract oxidative challenges in this fungal pathogen. Asp f3-like proteins are also highly conserved within the Aspergilli. For example Asp f3 from A. fumigatus shares 90% amino acid identity with its homologue in A. nidulans. The latter is a Prx5-like protein (Uniprot accession number Q5ASN8), which was identified as a major thioredoxin binding protein, and is under transcriptional control of the CCAAT binding complex that coordinates the oxidative stress response in eukaryotes23,24.
ROS production is a central element of the host immune response and a severe hereditary defect such as CGD represents a high-risk for IA with incidence rates ranging from 20–40%5. Patients suffering from CGD share mutations in components of the NADPH oxidase (NOX) complex which lead to a reduced production of superoxide radicals ·O2− and hence, compromise the microbiocidal activity of phagocytes. Indeed we demonstrated in vitro that fungistasis of the asp f3 mutant was observed at 25 μM of X corresponding approximately to 12.5 μM of ·O2−. Intriguingly, this is within the concentration range predicted for phagocytic cells25, indicating that NOX derived ·O2− could directly affect the redox homeostasis of A. fumigatus. Such conclusion is in line with a previous study which reported that inhibition of the fungal thioredoxin-1 facilitates killing during interactions with neutrophil granulocytes26. Consequently, we expected that such ·O2− dependent fungistasis should also reduce the virulence of A. fumigatus when facing a partially intact innate immune system. Corticosteroid-mediated immunosuppression of patients represents a high risk factor for fungal infections and is widely used in mouse models of IA. Upon infection with A. fumigatus corticosteroid-treated mice are characterized by high neutrophil counts and a massive increase in the release of myeloperoxidase27. Despite histological evidence of viable fungus in the murine airways, none of the mice infected with the asp f3 deletion mutant died over the course of the experiment, indicating that the fungal ROS hypersensitivity contributed to reduced virulence. This conclusion is consistent with ROS mediated damage to be attributed to the killing capacity of innate immune cells28,29. Therefore, it will be interesting to further elucidate the role of Asp f3 in host pathogen interactions. Future research may consider targeting the Prx activity of Asp f3 for therapeutic purposes.
Materials and Methods
Chemicals and media were from Sigma, Saint Louis, MO, unless otherwise indicated.
Recombinant Asp f3, WT, mutants, expression and purification
Recombinant N-terminally His-tagged Asp f3 was produced earlier in our laboratory7. However, we were unable to crystallize it. Therefore, we generated another version of the protein, this time with the His tag at the C-terminus. In brief, we PCR amplified the Asp f3 insert from the original pMK2Aspf3 plasmid7 and cloned it into a pET28 vector (Novagen, EMD Biosciences, Madison, WI) using primers WTf and WTr (Supplementary Table S2) that encoded NcoI and NotI sites, respectively. Cysteine mutants were obtained with the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent, Santa Clara, CA) using primers C31Af, C31Ar, C61Af, C61Ar, C31Sf, C31Sr, C61Af, and C61Ar (Supplementary Table S2). The resulting constructs were then transformed into the TOP10 competent cells (Thermo Fisher Scientific, Rockford, IL). Asp f3 was expressed in ClearColi BL21(DE3) E. coli cells (Lucigen, Middleton, WI) using 1 L terrific broth (BioPioneer, San Diego, CA) in presence of kanamycin (25 μg/mL), induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) (0.1 mM), and cultured at 25 °C on an orbital shaker at 220 rpm for 16 hours. The bacteria were pelleted at 2000 × g and lysed with B-PER Complete Bacterial Protein Extraction Reagent (Thermo Fisher Scientific, Rockford, IL) containing 1× Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific) and 10 units of Deoxyribonuclease I (Thermo Fisher Scientific). 10 mL lysate were passed through a 10-mL gravity flow column (Thermo) containing HisPur Ni-NTA resin (1 mL, Thermo), washed with 20 mL wash buffer (NaCl – 300 mM, Tris HCl – 20 mM, imidazole – 40 mM, at pH 7.4), and eluted with a wash buffer-based elution buffer (20 mL) in which the imidazole concentration was raised to 400 mM. The eluted protein was buffer exchanged by ultrafiltration on a YM-10 Centricon (Millipore) into FPLC buffer (NaCL–150 mM, Tris HCl – 20 mM, pH 8.0), and finally separated by size-exclusion chromatography on an ÄKTA purifier with a HiLoad Superdex 75 PG column (GE Healthcare, Pittsburgh, PA).
Crystallization, data collection, and structure determination
Initial crystallization conditions were identified using Microlytic’s MCSG-1 suite (Microlytic North America, Burlington MA) by vapor diffusion. Diffraction quality crystals of WT and cysteine variants of Aspf3 (both at 20 mg/ml) were obtained by vapor diffusion by mixing 1 μL of protein and 1 μL of the mother liquor (100 mM MES, pH 6.5, 25 mM NaCl and 27% [w/v] PEG3350, or 100 mM Tris, pH 7.2, 300 mM MgCl2 and 22% [w/v] PEG3350, for WT and C31S/C61S, respectively). The crystals were quickly wicked through the mother liquor containing 15–20% [w/v] meso-erythritol and frozen in the nitrogen stream of the diffractometer at 100 K. Diffraction data was collected at 1.5418 Å on the home source, a Rigaku MicroMax-007HF with R-Axis IV++detector. Diffraction data was processed and reduced using XDS, XSCALE and XDSCONV30. A Blast search against PDB database suggested that thioredoxin reductase from B. cenocepacia (PDB ID: 4F82) could serve as a potential model for molecular replacement (Blast E-value = 5 × 10−29). After failing to find a solution using the entire 4F82 model, flexible loops were removed and initial phases were obtained using Molrep31. Model rebuilding was done in Coot32. The refinement, and simulated annealing composite omit maps were performed in PHENIX33.
The crystallized recombinant Asp f3 contains an additional glycine residue in position 2 and a hexahistidine tag in position 170–175. Despite this and to simplify comparisons with native Asp f3, we are using the residue numbering of the published A. fumigatus Asp f3 sequences, NCBI reference accession numbers XP_747849, KEY83680, XP_747849, KMK55366, and EDP47753, in this publication. Both structures have been deposited at RSCB PDB (http://www.rcsb.org). PDB structure identifiers are 5J9B for WT Asp f3 and 5J9C for the C31S/C61S mutant.
Protein samples (WT Aspf3 and C31S/C61S variant) were dialyzed overnight into phosphate-buffered saline (PBS), pH 7.4 (Slide-A-Lyzer MINI, 7000 MWCO, Thermo Fisher Scientific). Protein concentrations for the experiment were adjusted to optical density at A280 ~0.2, ~0.5 and ~0.8 (corresponding to ~5, ~15 and ~25 μM). To reduce disulfide bonds, a sample of WT protein in 1 mM TCEP in PBS was also analyzed. Sedimentation equilibrium experiments were performed using Beckman XL-I Proteomelab at 10000, 20000, and 30000 rpm, at 25 °C. Data was analyzed using Sedfit and Sedphat34.
A. fumigatus culture conditions
All fungal strains were stored in 20% (v/v) glycerol at −80 °C as conidia suspensions. These glycerol stocks were used to inoculate agar plates with AMM35. Conidia were harvested from surface culture grown for 5 d at 37 °C by rinsing with 0.1% [v/v] Tween-80. Fresh conidial suspensions were used to inoculate any liquid cultures at 103–105 conidia per mL and cultivated at 37 °C in either 24-well tissue culture plates (VWR International, Leuven, Belgium) or Erlenmeyer flasks on a rotary incubator at 200 rpm.
Asp f3 gene deletion and complementation
A. fumigatus D141 is a clinical isolate and was a gift from Utz Reichard, Universitätsmedizin Göttingen, Germany36. Deletion of the asp f3 gene in A. fumigatus D141 was achieved by homologous recombination using the shuttle plasmid pAspf3-del. For construction of the plasmid, the two flanking chromosomal regions of the asp f3 gene were amplified by nested PCR using primer AspF3-1 to AspF3-8 (Supplementary Table S2) and cloned into pBluescript II SK(+). A DNA cassette delivering hygromycin resistance was obtained from pME3002 and was inserted between both flanking regions using SfiI restriction sites37. For complementation the 2.7 kbp fragment covering the asp f3 gene with 1600 bp and 250 bp of the upstream and downstream regions, respectively, was amplified and cloned into pSK275 (a kind gift from Sven Krappmann, Friedrich-Alexander-University of Erlangen-Nürnberg, Germany) using XmaI restriction sites and conferring resistance to the antimetabolite pyrithiamine. Plasmids were transformed into A. fumigatus using protoplast-transformation as described35. Transformants were either selected for resistance against hygromycin (250 μg/mL, Invivogen, Toulouse, France) or pyrithiamine (0.1 μg/mL, Sigma-Aldrich, Taufkirchen, Germany) and conidia underwent at least two successive rounds of selection to avoid heterokaryon contamination. Chromosomal integrations in the asp f3 deleted strain (Δasp f3) and the complemented strain (asp f3C) were verified by Southern hybridizations.
Analysis of Asp f3 protein expression
A. fumigatus D141, Δasp f3, and asp f3C strains were grown in PD medium at 37 °C for 24 h. The fungal material was separated from culture supernatant by centrifugation at 5,000 g. Proteins were extracted by sonication in presence of protease inhibitor cocktail, and then separated by SDS polyacrylamide electrophoresis (PAGE). 0.5 μg total protein (from ~10 mg dry hyphae) was loaded per lane and recombinant Asp f3 served as a positive control. Protein gels were stained with SimplyBlue SafeStain (Thermo Fisher Scientific) or used for Western blots developed with a previously described rabbit polyclonal anti-Asp f3 antibody and the IRDye 680RD donkey-anti-rabbit antibody (Li-Cor) as the secondary antibody8. The blots were scanned with a Li-Cor Odyssey infra-red Imaging System (Li-Cor Biotechnology, Lincoln, NE).
Isolation of chromosomal DNA from A. fumigatus and Southern Hybridization
DNA was isolated from overnight liquid cultures of A. fumigatus. The mycelium was separated from the medium by filtration, frozen in liquid N2 and ground to a fine powder in a mortar. Genomic DNA was extracted using the MasterPure yeast DNA purification kit (Epicenter Biotechnologies, Madison, WI, USA). For Southern hybridizations, restriction enzyme digested genomic DNA was separated on 1% (w/v) agarose gels and blotted onto Hybond-N+ membranes (GE Healthcare Europe, Freiburg, Germany). Blotting and hybridization procedures followed standard protocols38. Digoxigenin (DIG)-labeled probes were generated by adding DIG-11-dUTPs (Jena Bioscience GmbH, Jena, Germany) to the nucleotide pool of PCR reactions and were directed against a 430-bp fragment of the upstream region of the asp f3 gene. Hybridization signals were detected using CDPstar® as a highly sensitive chemiluminescent substrate of alkaline phosphatase coupled to an Anti-DIG-antibody (Roche Applied Science, Mannheim, Germany).
Effect of oxidative stress on A. fumigatus’ viability
Fungal resistance to oxidative stress was assessed by exposure to various oxidative stressors. Resistance to high levels of oxidative stress was tested in agar diffusion assays by adding hydrogenperoxide (H2O2) tert-butyl hydroperoxide solution (t-bOOH) or menadione in varying concentrations (50 μL aliquots) to a central cavity of agar plates pre-inoculated with 105 conidia of A. fumigatus. Diameters of inhibition zones were measured 18 h after incubation at 37 °C. The data displayed are mean values from four biological replicates and error bars indicate standard deviations. Lower concentrations of the oxidative stressors were required for the direct exposure assays to determine the minimal inhibitory concentration for H2O2, t-bOOH, and in situ generated superoxide (O2−). Conidia (105 per mL) were transferred into liquid Czapek Dox medium (BD, Franklin Lakes, NJ) and distributed onto 24-well tissue culture plates (VWR International, Leuven, Belgium) in a final volume of 500 μl and cultured at 37 °C. After 6 h, H2O2 or t-bOOH were added to the cultures in varying concentrations. The xanthine-oxidase enzymatic system was used to generate O2− in vitro18,19. Xanthine was added to each well up to final concentration of 250 μM, and the reaction was started by addition of 100 μg/mL (0.2 units/mL) xanthine oxidase (Sigma X4500). Where indicated, wells were also containing superoxide dismutase at 20 units/mL (Sigma S4636). After an additional 18 h, total cell wall chitin was determined as an indirect measure for fungal growth by staining with Calcufluor White (Fluorescence brightener 28, Sigma) at a final concentration of 0.1 mg/mL. After 5 min of incubation, plates were washed three times and total fluorescence was measured in an Infinite® 200 PRO fluorometer (TECAN, Männedorf, Switzerland) at 360 nm (excitation) and 440 nm (emission). Data displayed are based on three biological replicates and with standard deviations given as error bars.
Peroxiredoxin (Prx) activity enzymatic assays
Prx activity was measured with a fluorometric assay that detected the reduction of H2O2 or t-bOOH in the presence of E. coli thioredoxin (Trx) and Ampliflu Red (10-acetyl-3,7-dihydroxyphenoxazine). Ampliflu Red stock solutions were prepared in DMSO at 2 mg/mL, aliquoted and stored at −20 °C. The reaction mix (100 μL) contained a series of dilutions of H2O2 or t-bOOH (1 nM to 500 μM) and Ampliflu Red (2 μg/mL) in 50 mM sodium phosphate (pH 7.4). WT Asp f3 or mutants were used at 5 μM final concentrations. Horse radish peroxidase (HRP), 10 pM, served as a positive control, and was also used to generate standard curves with H2O2 or t-bOOH substrates (Supplementary Fig. S9). The time-dependent fluorescence of the reaction product was measured using 535/585 nm excitation/emission wavelengths on a SpectraMax M2 fluorometer (Molecular Devices, Sunnyvale, CA) (Supplementary Fig. S8). Pre-reduction of peroxiredoxins or thioredoxin was performed with DTT (100 mM) for 1 hour at 22 °C as recommended in ref. 39. DTT was then removed from the sample using 3 kDa MWCO Vivaspin 500 centrifugal filter units (BioExpress, Kaysville, UT). Prx activity was calculated using the H2O2 or t-bOOH standard curve generated with HRP (Supplementary Fig. S9). The method was validated by an alternative photospectrometric assay that measures reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent Prx activity in presence of reduced glutathione (GSH), glutathione reductase (GSHR), and t-bOOH39. Kinetic measurements were performed using 100 μL of reaction mix containing potassium phosphate (25 mM), pH 7.0, EDTA (1 mM), GSH (5 μM), GSHR (0.5 μM) and t-bOOH (100 μM). NADPH was added at the final concentration of 150 μM after which the absorbance at 340 nm was monitored for 20 min in presence or absence of Asp f3 protein and mutants. All assays were performed in triplicate, with error bars indicating standard deviation. Data analysis was performed with Prism 6.0 software (GraphPad software, La Jolla, CA).
Murine aspergillosis model
Pathogen-free female outbreed CD-1 mice (18–20 g, 6–8 weeks old, Charles River, Germany) were housed under standard conditions in individually ventilated cages, and fed with normal mouse chow and water ad libitum. Mice were immunosuppressed with two single doses of 25 mg cortisone acetate (Sigma Aldrich) suspended in PBS, injected intraperitoneally (i.p.) 3 days before and immediately prior to infection with conidia on day 0. To establish fungal infections, mice were anaesthetized by i.p. injection with midazolam (5 mg/kg), fentanyl (0.05 mg/kg), and medetomidine (0.5 mg/kg), and a 20 μL suspension of conidia (2 × 105) in PBS were applied to the nares. Deep anesthesia ensured inhalation of the conidial inoculums. Anesthesia was terminated by subcutaneous injection of flumazenil, naloxon and atipamezol as described40. Mouse group sizes were n = 10 (infected strains) an n = 3 (PBS controls). Infected animals were monitored twice daily for weight loss, and moribund animals were sacrificed humanely. Fixation, Periodic acid-Schiff (PAS) and methenamine silver staining for histopathological analysis of the lungs of sacrificed mice was carried out as previously described41.
Mice were cared for in accordance with the principles outlined by the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes. (http://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/123). All experiments involving animals were in compliance with the German animal protection law and were approved by the responsible Federal State authority “Thüringer Landesamt für Verbraucherschutz (TLV)” and ethics committee “Beratende Komission nach § 15 Abs. 1 Tierschutzgesetz” with the permit Reg.-Nr. 03-001/12.
Accession codes:The two crystal structures reported in this manuscript have been deposited at the Protein Data Bank (http://www.rcsb.org) as described in the text. PDB structure identifiers are 5J9B for wild type Asp f3 and 5J9C for the C31S/C61S mutant.
How to cite this article: Hillmann, F. et al. The Crystal Structure of Peroxiredoxin Asp f3 Provides Mechanistic Insight into Oxidative Stress Resistance and Virulence of Aspergillus fumigatus. Sci. Rep. 6, 33396; doi: 10.1038/srep33396 (2016).
Latge, J. P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12, 310–350 (1999).
Brakhage, A. A. & Langfelder, K. Menacing mold: the molecular biology of Aspergillus fumigatus. Annual review of microbiology 56, 433–455, doi: 10.1146/annurev.micro.56.012302.160625 (2002).
Baddley, J. W. et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 50, 1559–1567, doi: 10.1086/652768 (2010).
Wiederhold, N. P., Lewis, R. E. & Kontoyiannis, D. P. Invasive aspergillosis in patients with hematologic malignancies. Pharmacotherapy 23, 1592–1610 (2003).
Henriet, S., Verweij, P. E., Holland, S. M. & Warris, A. Invasive fungal infections in patients with chronic granulomatous disease. Adv Exp Med Biol 764, 27–55 (2013).
Hemmann, S., Ismail, C., Blaser, K., Menz, G. & Crameri, R. Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus. Clin Exp Allergy 28, 860–867 (1998).
Ito, J. I. et al. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. Infect Immun 74, 5075–5084, doi: 10.1128/IAI.00815-06 (2006).
Diaz-Arevalo, D., Bagramyan, K., Hong, T. B., Ito, J. I. & Kalkum, M. CD4+ T Cells Mediate the Protective Effect of the Recombinant Asp f3-Based Anti-Aspergillosis Vaccine. Infect Immun 79, 2257–2266, doi: IAI.01311-10 [pii]10.1128/IAI.01311–10 (2011).
Diaz-Arevalo, D., Ito, J. I. & Kalkum, M. Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine. Frontiers in Microbiology 3, doi: 10.3389/fmicb.2012.00299 (2012).
Lessing, F. et al. The Aspergillus fumigatus Transcriptional Regulator AfYap1 Represents the Major Regulator for Defense against Reactive Oxygen Intermediates but Is Dispensable for Pathogenicity in an Intranasal Mouse Infection Model. Eukaryotic Cell 6, 2290–2302, doi: 10.1128/ec.00267-07 (2007).
Karplus, P. A. & Hall, A. Structural survey of the peroxiredoxins. Subcell Biochem 44, 41–60 (2007).
Pan, J. L. & Bardwell, J. C. The origami of thioredoxin-like folds. Protein Sci 15, 2217–2227, doi: 10.1110/ps.062268106 (2006).
Martin, J. L. Thioredoxin–a fold for all reasons. Structure 3, 245–250 (1995).
Holm, L. & Rosenstrom, P. Dali server: conservation mapping in 3D. Nucleic acids research 38, W545–W549, doi: 10.1093/nar/gkq366 (2010).
Lian, F. M. et al. Structural snapshots of yeast alkyl hydroperoxide reductase Ahp1 peroxiredoxin reveal a novel two-cysteine mechanism of electron transfer to eliminate reactive oxygen species. J Biol Chem 287, 17077–17087, doi: 10.1074/jbc.M112.357368 (2012).
Criddle, D. N. et al. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J Biol Chem 281, 40485–40492, doi: 10.1074/jbc.M607704200 (2006).
Rada, B. & Leto, T. L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 15, 164–187, doi: 10.1159/000136357 (2008).
Gort, A. S., Ferber, D. M. & Imlay, J. A. The regulation and role of the periplasmic copper, zinc superoxide dismutase of Escherichia coli. Mol Microbiol 32, 179–191 (1999).
Riebe, O., Fischer, R. J. & Bahl, H. Desulfoferrodoxin of Clostridium acetobutylicum functions as a superoxide reductase. FEBS Lett 581, 5605–5610 (2007).
McCord, J. M. & Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244, 6049–6055 (1969).
Declercq, J. P. et al. Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 A resolution. J Mol Biol 311, 751–759, doi: 10.1006/jmbi.2001.4853 (2001).
Wood, Z. A., Schroder, E., Robin Harris, J. & Poole, L. B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28, 32–40 (2003).
Thon, M., Al-Abdallah, Q., Hortschansky, P. & Brakhage, A. A. The thioredoxin system of the filamentous fungus Aspergillus nidulans: impact on development and oxidative stress response. J Biol Chem 282, 27259–27269 (2007).
Thon, M. et al. The CCAAT-binding complex coordinates the oxidative stress response in eukaryotes. Nucleic acids research 38, 1098–1113, doi: 10.1093/nar/gkp1091 (2010).
Winterbourn, C. C., Hampton, M. B., Livesey, J. H. & Kettle, A. J. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281, 39860–39869 (2006).
Leal, S. M. Jr. et al. Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Invest 122, 2482–2498 (2012).
Balloy, V., Huerre, M., Latgé, J.-P. & Chignard, M. Differences in Patterns of Infection and Inflammation for Corticosteroid Treatment and Chemotherapy in Experimental Invasive Pulmonary Aspergillosis. Infect Immun 73, 494–503, doi: 10.1128/iai.73.1.494-503.2005 (2005).
Philippe, B. et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 71, 3034–3042 (2003).
Washburn, R. G., Gallin, J. I. & Bennett, J. E. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun 55, 2088–2092 (1987).
Kabsch, W. Xds. Acta Crystallogr D Biol Crystallogr 66, 125–132, doi: 10.1107/S0907444909047337 (2010).
Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr 66, 22–25, doi: 10.1107/S0907444909042589 (2010).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486–501, doi: 10.1107/S0907444910007493 (2010).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213–221, doi: 10.1107/S0907444909052925 (2010).
Schuck, P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal Biochem 320, 104–124 (2003).
Weidner, G., d’Enfert, C., Koch, A., Mol, P. C. & Brakhage, A. A. Development of a homologous transformation system for the human pathogenic fungus Aspergillus fumigatus based on the pyrG gene encoding orotidine 5′-monophosphate decarboxylase. Curr Genet 33, 378–385 (1998).
Reichard, U., Buttner, S., Eiffert, H., Staib, F. & Ruchel, R. Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol 33, 243–251 (1990).
Krappmann, S., Sasse, C. & Braus, G. H. Gene targeting in Aspergillus fumigatus by homologous recombination is facilitated in a nonhomologous end- joining-deficient genetic background. Eukaryot Cell 5, 212–215 (2006).
Sambrook, J. Molecular Cloning: A Laboratory Manual/Joseph Sambrook, David W. Russell. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory (2001).
Nelson, K. J. & Parsonage, D. Measurement of peroxiredoxin activity. Curr Protoc Toxicol Chapter 7, Unit7 10, doi: 10.1002/0471140856.tx0710s49 (2011).
Slesiona, S. et al. Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages. Plos One 7, 3 (2012).
Hillmann, F. et al. The novel globin protein fungoglobin is involved in low oxygen adaptation of Aspergillus fumigatus. Mol Microbiol 93, 539–553 (2014).
We thank Dr. Utz Reichard and Sven Krappmann for providing us with the Asp f3 knockout mutant and the corresponding parental A. fumigatus strain (D141). Andrea Wong is thanked for helping with the re-cloning of Asp f3 into the pET vector. KB, TBH, and MK, were supported in part by the Hermann Foundation. This study was supported in part by the Leibniz Association, the German Research Foundation DFG, Grant HI 1574/2-1, and the BMBF-funded Consortium InfectControl 2020 (project no. 03ZZ0803A). City of Hope facilities, including the Drug Discovery and Structural Biology Core used in this study were supported in parts by National Cancer Institute of the National Institutes of Health under award number P30 CA33572. JCW acknowledges support from the Leo and Anne Albert Trust.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Hillmann, F., Bagramyan, K., Straßburger, M. et al. The Crystal Structure of Peroxiredoxin Asp f3 Provides Mechanistic Insight into Oxidative Stress Resistance and Virulence of Aspergillus fumigatus. Sci Rep 6, 33396 (2016). https://doi.org/10.1038/srep33396
This article is cited by
Comparative proteome analysis identifies species-specific signature proteins in Aspergillus pathogens
Applied Microbiology and Biotechnology (2023)
Increasing NADPH impairs fungal H2O2 resistance by perturbing transcriptional regulation of peroxiredoxin
Bioresources and Bioprocessing (2022)
Cellular and Molecular Life Sciences (2022)
Applied Microbiology and Biotechnology (2021)
Yeast two-hybrid screening reveals a dual function for the histone acetyltransferase GcnE by controlling glutamine synthesis and development in Aspergillus fumigatus
Current Genetics (2019)